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In the past, there were many traditional methods for detection 
of  cardiac injury. These methods includes electrocardiography, 
echocardiography in association with certain cardiac biomarkers. 
The serum levels of  aspartate aminotransferase (AST), creatin ki-
nase (CK), and lactate dehydrogenase (LDH) were formerly used 
as cardiac biomarkers until the identification of  creatine kinase 
myocardial band (CK-MB), LDH-1 and LDH-2 isomers, which 
are more specific to cardiac and muscle injury.  Recently these 
enzymes were discovered to be lack of  sensitivity and specificity 
in the presence of  either cardiac or muscle injury in human or ani-
mals. Therefore, there has been a great interest in human and ani-
mal medicine to investigate an innovative heart marker to be used 
as diagnostic and prognostic tools for human and animal cardiac 
problems. Cardiac troponin I (cTnI), is an extremely sensitive and 
precise heart biomarker for diagnosis of  myocardial damage in 
humans and as well as in animals.  The cTnI is a regulatory pro-
tein that control the calcium mediated interaction between actin 
and myosin (regulate cardiac contraction). Thetroponin complex 
consists of  three subunits: troponin T,which binds to tropomyo-
sin and facilitates contraction;troponin I, which binds to actin and 
inhibits actin-myosininteractions; and troponin C, which binds 
to calcium ions. The amino acid sequences of  the cardiac and 
skeletal isoforms of  troponin I and troponin T are satisfactorily 
different and, consequently, differentially measureable by mono-
clonal antibody based assays. Troponin C is not used clinically 
because both the cardiac and skeletal muscle share troponin C 
isoforms. Cardiac troponin I is 13 times more copious in the heart 
than creatine kinase
MB isoenzyme, subsequently the signal-to-noise ratio allied with 
troponin I is much more promising for the discovery of  minor 
levels of  cardiac injury. Cardiac troponin T is as copious as tro-
ponin I in the heart muscles.It was stated that the values of  serum 
cTnI are increased in response to cardiac injury as a consequence 
of  enzyme leakage from the cardiac cell. Variations in serum val-
ues of  cardiac troponins have  been established to be specific 
andsensitive markers of  myocardium injury in human (withsensi-
tivity of  94 % and specificity of  81%) and dog (withsensitivity of  
70-100 % and specificity of  65-81%)
The values of  cTn1 in relations to parasitic infestation was stud-
ied in dogs infected with Dirofilaria immitis, with leishmaniasis and 
with babesiosis.  In the same concern, cTnI is obviously increased 
in bovine thieleriosis. In addition, it is used for diagnosis of  acute 
white muscle disease in lambs and kids, pregnancy toxemia in-
goatsand in pre-clinical toxicology. Moreover, it was detected that 
cardiac injuries can be persuaded during experimental induction 
of  endotoxaemia by E. coli serotype O55:B5 administration and 
also by acute ruminal lactic acidosis in sheep. In horses' there are 
many studies concerning the uses of  cardiac troponin as a diag-
nostic biomarkers in many clinical conditions, as evaluation of  
poor performance in athletic horses and in equine colic.
In dromedary camels, there are few literatures regarding the use 
of  cTnI in camels. The levels of  cTnI has been used recently as 
a new marker for cardiac injury during camel transportation and 
camels with tick infestation.  Future research should be focused 
in the use of  this enzymeas diagnostic and prognostic biomarker 
in cases suspected to cause cardiac injury.
